- Home
- MAIA vs VHC Comparison
MAIA vs VHC Comparison
Compare MAIA & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- VHC
- Stock Information
- Founded
- MAIA 2018
- VHC 2005
- Country
- MAIA United States
- VHC United States
- Employees
- MAIA N/A
- VHC N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- VHC Multi-Sector Companies
- Sector
- MAIA Health Care
- VHC Miscellaneous
- Exchange
- MAIA Nasdaq
- VHC Nasdaq
- Market Cap
- MAIA 56.3M
- VHC 54.3M
- IPO Year
- MAIA 2022
- VHC 1999
- Fundamental
- Price
- MAIA $1.59
- VHC $18.88
- Analyst Decision
- MAIA
- VHC
- Analyst Count
- MAIA 0
- VHC 0
- Target Price
- MAIA N/A
- VHC N/A
- AVG Volume (30 Days)
- MAIA 375.5K
- VHC 9.6K
- Earning Date
- MAIA 08-11-2025
- VHC 08-12-2025
- Dividend Yield
- MAIA N/A
- VHC N/A
- EPS Growth
- MAIA N/A
- VHC N/A
- EPS
- MAIA N/A
- VHC N/A
- Revenue
- MAIA N/A
- VHC $50,000.00
- Revenue This Year
- MAIA N/A
- VHC N/A
- Revenue Next Year
- MAIA N/A
- VHC N/A
- P/E Ratio
- MAIA N/A
- VHC N/A
- Revenue Growth
- MAIA N/A
- VHC 733.33
- 52 Week Low
- MAIA $1.40
- VHC $3.68
- 52 Week High
- MAIA $3.74
- VHC $21.53
- Technical
- Relative Strength Index (RSI)
- MAIA 50.99
- VHC 65.48
- Support Level
- MAIA $1.46
- VHC $14.30
- Resistance Level
- MAIA $1.65
- VHC $20.11
- Average True Range (ATR)
- MAIA 0.09
- VHC 1.32
- MACD
- MAIA 0.01
- VHC 0.66
- Stochastic Oscillator
- MAIA 43.10
- VHC 83.84
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.